Sequent Scientific Limited (SEQUENT.NS) NSE



As of June 21 03:29PM

Currency In INR

Sequent Scientific Limited


Dosti Pinnacle

Mumbai, 400604



91 22 4111 4777




Drug Manufacturers - Specialty & Generic



First IPO Date

March 10, 2016

Key Executives

NameTitlePayYear Born
Mr. Rajaram NarayananMD, Chief Executive Officer & Director49.17M1968
Mr. Saurav BhalaChief Financial Officer0N/A
Mr. Ravi NairExecutive Vice President of Human Resources & Administration0N/A
Mr. Phillip TrottSecretary, Compliance Off., Assoc. Vice President, Head of Legal, Secretarial & Compliance and Chief Risk Off.0N/A
Mr. Prasad LadVice President of HR & Administration0N/A
Mr. Ramesh Kumar PillaiCorporate Vice President of Ra Qa and Technical Services01965
Mr. Abhishek SinghalHead of Investor Relations0N/A


Sequent Scientific Limited engages in the animal health business worldwide. The company provides animal health active pharmaceutical ingredients (APIs) and finished dosage formulations in the areas of feed supplements, antibiotics, anthelmintics, antibacterial, anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It offers analytical solutions that supports API, pharmaceutical, personal care, and nutraceutical organizations, as well as provides method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to Sequent Scientific Limited in October 2009. Sequent Scientific Limited was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited operates as a subsidiary of CA Harbor Investments.